Triastek Advances 3D Printed D23 Budesonide Tablets for IgAN Treatment
Chinese drug 3D printing firm Triastek has announced that its 3D printed drug product, D23, Budesonide Ileum Targeted Tablets for the treatment of IgAN (Immunoglobulin A Nephropathy)—a kidney disorder characterized by the buildup of immunoglobulin A (IgA) deposits in the kidneys—has demonstrated favorable results in a recent clinical study.
MB Therapeutics €2 Million Seed Funding to Support Personalized Medicine Production
MB Therapeutics, a Montpellier-based startup with over 8 years of expertise in pharmaceutical 3D printing, has secured €2 million in seed funding to develop the first pharmaceutical facility designed to provide 3D printing compatible solutions for pharmacies. This facility will help pharmacies produce personalized medicines on-site, improving precision and meeting the growing demand for individualized treatments. The funding will also enable the launch of three high-demand medicines and prepare the company for a Series A funding round in 2026.
3D Printed Models Create New Paths for Treating Herpes Simplex Virus (HSV)
In the battle against herpes simplex virus (HSV), 3D printing technology is offering a new approach to drug development by creating models of human skin. Current antiviral drugs often fall short because they cannot replicate the complexity of human tissue. To address this, Dr. Jia Zhu from the Fred Hutch Vaccine and Infectious Disease Division, alongside biofabrication experts Dr. Ian Hayman and Dr. Tori Ellison, is using 3D printing to develop these models, enhancing the precision of virus studies.
3D Systems launches its latest multi-material dental 3D printing solutions
US-based 3D printer manufacturer 3D Systems has introduced its latest developments in dental 3D printing at LMT Lab Day 2025 at the Hyatt Regency Chicago.
Former 3D Systems’ medical division VP launches new biotechnology startup
Katie Weimer, former Vice President of Regenerative Medicine 3D Systems’ has launched GenesisTissue Inc., a biotechnology research startup.
Luyten CEO to live in 3D printed multi-storey home in Melbourne Construction 3D Printing
Luyten, an Australian construction 3D printing firm, is breaking ground on a new project in its home city of Melbourne. When complete, the 350-square-meter build will be Australia’s first multi-storey 3D printed home and will be lived in by none other than Luyten’s CEO and Global President Ahmed Mahil in an effort to demonstrate the viability of 3D printed homes.
ICC releases ICC 1150 standard for 3D printed concrete walls Construction 3D Printing
The International Code Council (ICC) has announced the development of ICC 1150, the first-ever standard for 3D Automated Construction Technology (3DACT) for 3D Concrete Walls. This standard aims to provide comprehensive structural criteria for interior and exterior 3D printed concrete walls, supporting load-bearing, non-load-bearing, and shear wall applications in single-story and multi-story structures.
Auxilium Biotechnologies 3D prints medical devices in Space
Auxilium Biotechnologies, a San Diego medtech startup, is 3D printing medical devices in space. The company uses a DLP-based bioprinter called the Auxilium Microfabrication Platform (AMP-1) to create biomimetic devices for nerve injuries. A recent deployment of the AMP-1 to the International Space Station (ISS) resulted in a successful test, described by Auxilium CEO Jacob Koffler as “a landmark achievement for space biomanufacturing.”
